| 000 | 01789 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516043920.0 | ||
| 264 | 0 | _c20120123 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1523-4681 | ||
| 024 | 7 |
_a10.1002/jbmr.455 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRousseau, Julie | |
| 245 | 0 | 0 |
_aFormulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _cOct 2011 |
||
| 300 |
_a2452-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aOsteolysis _xgenetics |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aRANK Ligand _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aEscriou, Virginie | |
| 700 | 1 | _aLamoureux, François | |
| 700 | 1 | _aBrion, Régis | |
| 700 | 1 | _aChesneau, Julie | |
| 700 | 1 | _aBattaglia, Séverine | |
| 700 | 1 | _aAmiaud, Jérome | |
| 700 | 1 | _aScherman, Daniel | |
| 700 | 1 | _aHeymann, Dominique | |
| 700 | 1 | _aRédini, Françoise | |
| 700 | 1 | _aTrichet, Valérie | |
| 773 | 0 |
_tJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research _gvol. 26 _gno. 10 _gp. 2452-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbmr.455 _zAvailable from publisher's website |
| 999 |
_c20967145 _d20967145 |
||